- Revenue Miss: Maximus, Inc. reported Q2 revenue of $1.31 billion, falling short of analyst expectations of $1.32 billion and marking a 4.1% year-over-year decline.
- Mixed EPS Performance: The company’s diluted earnings per share (EPS) was $1.80, missing estimates, while its adjusted EPS of $2.07 surpassed the consensus.
- Positive Outlook: Maximus, Inc. raised its full-year adjusted EPS guidance to a range of $8.25 to $8.55 and maintains a strong financial position with a low Debt-to-Equity ratio of 0.03.
Maximus, Inc. (NYSE:MMS) is a company that provides essential business process services to government health and human services agencies. It specializes in helping manage and administer large government-sponsored programs, operating in a competitive market to secure and manage these significant government contracts.
On May 7, 2026, Maximus, Inc. reported its second-quarter earnings results. The company’s revenue is approximately $1.31 billion, which slightly misses the analyst expectation of $1.32 billion. This revenue figure also marks a 4.1% decline from the same quarter in the previous year, reflecting current market dynamics in government services.
The company’s earnings report shows a diluted earnings per share (EPS) of $1.80. This figure, which represents the company’s profit divided by its outstanding shares, falls short of the consensus estimate of $1.98. This is the standard, or GAAP, measure of earnings performance.
However, Maximus, Inc. also reports an adjusted EPS of $2.07. This adjusted figure, which removes the impact of certain expenses to show core performance, beats the consensus estimate of $1.98, as highlighted by Zacks. It provides a different view of the company’s operational profitability for the quarter, offering key investment insights.
Following these financial results, Maximus, Inc. raises its full-year guidance. The company now projects an adjusted EPS in the range of $8.25 to $8.55. Maximus, Inc. maintains a low Debt-to-Equity ratio of 0.03, showing it has very little debt compared to its shareholder equity, indicating strong financial health and balance sheet strength.
